Skip to main content
Clinical Trials/CTRI/2024/08/071846
CTRI/2024/08/071846
Not yet recruiting
Phase 3

A Comparative Clinical Study to evaluate the effect of Vaman Dhauti (Kunjal Kriya) and Guduchyadikwath in the management of Amalpitta. - NI

Dr Amanpreet Kaur0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis
Sponsor
Dr Amanpreet Kaur
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Amanpreet Kaur

Eligibility Criteria

Inclusion Criteria

  • Patients ready to give written consent.Patients presenting with classical features of Amlapitta.
  • Patients with chronicity of less than 3 years.

Exclusion Criteria

  • Patients not willing for the trial.Patients below age of 20 years and above 60 years of age.Patients using Aspirin or other NSAID’s Patients having any malignancy, history of gastric surgery, Cardiac problems, Tuberculosis, Diabetes Mellitus. Alarming symptoms like weight loss, GI bleeding and any other serious ailment.Patients having HIV, TB, or other grievous diseases.Any other patient considered unfit for inclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials